Fundraising Fox

Anelixis Therapeutics

Cambridge, US · Founded 2015 · Delaware corporation

Biotech

Founders & leadership

KB
Kent BransfordNamed on SEC filing
MM
Maeve McNallyNamed on SEC filing
TR
Theodore ReichNamed on SEC filing
SP
Steven PerrinNamed on SEC filing
PS
Paul SallaberryNamed on SEC filing
AN
Augie NietoNamed on SEC filing
EC
Eric CravenNamed on SEC filing
JH
James HeywoodNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7.9M disclosed across 3 rounds · 2017–2019

▶$1MraisedMay 2019 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Maeve McNallyExecutive Officer
  • Steven PerrinExecutive Officer, Director
  • Augie NietoDirector
  • Walter OgierDirector
Offering amount
$6M
Amount sold
$1M
Minimum investment
$50K
Sales commissions
$100K
Placement agents
Noble Capital Markets
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedApr 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • WALTER C. OGIERDirector
  • AUGIE NIETODirector
  • MAEVE MCNALLYExecutive Officer
  • STEVEN PERRINExecutive Officer, Director
Offering amount
$4.5M
Amount sold
$2.6M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedJun 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kent BransfordDirector
  • Maeve McNallyExecutive Officer
  • Theodore ReichDirector
  • Steven PerrinExecutive Officer, Director
  • Paul SallaberryDirector
  • Augie NietoDirector
  • Eric CravenDirector
  • James HeywoodDirector
Offering amount
$8M
Amount sold
$4.3M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Anelixis Therapeutics raised?
Anelixis Therapeutics has disclosed $7.9M raised across 3 rounds.
Where is Anelixis Therapeutics headquartered?
Anelixis Therapeutics is headquartered in Cambridge, US.